Literature DB >> 25728055

Refinement of genotype-phenotype correlation in 18 patients carrying a 1q24q25 deletion.

Nicolas Chatron1, Véronique Haddad, Joris Andrieux, Julie Désir, Odile Boute, Anne Dieux, Clarisse Baumann, Séverine Drunat, Marion Gérard, Céline Bonnet, Bruno Leheup, Marianne Till, Massimiliano Rossi, Elisabeth Flori, Yves Alembik, Helen Stewart, Joanna McParland, Laura Bernardini, Pia Castelluccio, Laura Roos, Zeynep Tümer, Kerry Fagan, Anna Hackett, Nicole Bain, Arie van Haeringen, Claudia Ruivenkamp, Brigitte Benzacken, Damien Sanlaville, Patrick Edery, Azzedine Aboura, Caroline Schluth-Bolard.   

Abstract

Interstitial deletion 1q24q25 is a rare rearrangement associated with intellectual disability, growth retardation, abnormal extremities and facial dysmorphism. In this study, we describe the largest series reported to date, including 18 patients (4M/14F) aged from 2 days to 67 years and comprising two familial cases. The patients presented with a characteristic phenotype including mild to moderate intellectual disability (100%), intrauterine (92%) and postnatal (94%) growth retardation, microcephaly (77%), short hands and feet (83%), brachydactyly (70%), fifth finger clinodactyly (78%) and facial dysmorphism with a bulbous nose (72%), abnormal ears (67%) and micrognathia (56%). Other findings were abnormal palate (50%), single transverse palmar crease (53%), renal (38%), cardiac (38%), and genital (23%) malformations. The deletions were characterized by chromosome microarray. They were of different sizes (490 kb to 20.95 Mb) localized within chromosome bands 1q23.3-q31.2 (chr1:160797550-192912120, hg19). The 490 kb deletion is the smallest deletion reported to date associated with this phenotype. We delineated three regions that may contribute to the phenotype: a proximal one (chr1:164,501,003-167,022,133), associated with cardiac and renal anomalies, a distal one (chr1:178,514,910-181,269,712) and an intermediate 490 kb region (chr1:171970575-172460683, hg19), deleted in the most of the patients, and containing DNM3, MIR3120 and MIR214 that may play an important role in the phenotype. However, this genetic region seems complex with multiple regions giving rise to the same phenotype.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  1q24q25 deletion; DNM3; brachydactyly; growth retardation; intellectual disability

Mesh:

Year:  2015        PMID: 25728055     DOI: 10.1002/ajmg.a.36856

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  13 in total

Review 1.  Chromosomal Microarrays: Understanding Genetics of Neurodevelopmental Disorders and Congenital Anomalies.

Authors:  Jill A Rosenfeld; Ankita Patel
Journal:  J Pediatr Genet       Date:  2016-05-30

2.  A de novo 1q23.3-q24.2 deletion combined with a GORAB missense mutation causes a distinctive phenotype with cutis laxa.

Authors:  Mohammed Al-Bughaili; Teresa M Neuhann; Ricarda Flöttmann; Stefan Mundlos; Malte Spielmann; Uwe Kornak; Björn Fischer-Zirnsak
Journal:  J Hum Genet       Date:  2016-09-08       Impact factor: 3.172

3.  Novel somatic PBX1 mosaicism likely masking syndromic CAKUT in an adult with bilateral kidney hypoplasia.

Authors:  Friederike Petzold; Wenjun Jin; Elena Hantmann; Katharina Korbach; Ria Schönauer; Jan Halbritter
Journal:  Clin Kidney J       Date:  2022-04-06

4.  Delineation of the 1q24.3 microdeletion syndrome provides further evidence for the potential role of non-coding RNAs in regulating the skeletal phenotype.

Authors:  James L Shepherdson; Hongjun Zheng; Ina E Amarillo; Audrey McAlinden; Marwan Shinawi
Journal:  Bone       Date:  2020-10-22       Impact factor: 4.398

Review 5.  The role of microRNAs in bone development.

Authors:  Austin P Hensley; Audrey McAlinden
Journal:  Bone       Date:  2020-11-19       Impact factor: 4.626

6.  Elucidation of the phenotypic spectrum and genetic landscape in primary and secondary microcephaly.

Authors:  Paranchai Boonsawat; Pascal Joset; Katharina Steindl; Beatrice Oneda; Laura Gogoll; Silvia Azzarello-Burri; Frenny Sheth; Chaitanya Datar; Ishwar C Verma; Ratna Dua Puri; Marcella Zollino; Ruxandra Bachmann-Gagescu; Dunja Niedrist; Michael Papik; Joana Figueiro-Silva; Rahim Masood; Markus Zweier; Dennis Kraemer; Sharyn Lincoln; Lance Rodan; Sandrine Passemard; Séverine Drunat; Alain Verloes; Anselm H C Horn; Heinrich Sticht; Robert Steinfeld; Barbara Plecko; Beatrice Latal; Oskar Jenni; Reza Asadollahi; Anita Rauch
Journal:  Genet Med       Date:  2019-03-07       Impact factor: 8.822

7.  Narrowing down the region responsible for 1q23.3q24.1 microdeletion by identifying the smallest deletion.

Authors:  Takao Hoshina; Toshiyuki Seto; Taro Shimono; Hiroaki Sakamoto; Torayuki Okuyama; Takashi Hamazaki; Toshiyuki Yamamoto
Journal:  Hum Genome Var       Date:  2019-10-18

8.  Heterozygous missense variants of LMX1A lead to nonsyndromic hearing impairment and vestibular dysfunction.

Authors:  Mieke Wesdorp; Pia A M de Koning Gans; Margit Schraders; Jaap Oostrik; Martijn A Huynen; Hanka Venselaar; Andy J Beynon; Judith van Gaalen; Vitória Piai; Nicol Voermans; Michelle M van Rossum; Bas P Hartel; Stefan H Lelieveld; Laurens Wiel; Berit Verbist; Liselotte J Rotteveel; Marieke F van Dooren; Peter Lichtner; Henricus P M Kunst; Ilse Feenstra; Ronald J C Admiraal; Helger G Yntema; Lies H Hoefsloot; Ronald J E Pennings; Hannie Kremer
Journal:  Hum Genet       Date:  2018-05-12       Impact factor: 4.132

9.  Prenatal diagnosis of a rare de novo 1q22-q25.1 chromosomal deletion syndrome using oligo array CGH.

Authors:  Gholamreza Shariati; Alihossein Saberi; Mohammad Hamid; Hamid Galehdari; Alireza Sedaghat; Nehzat Abdorasuli
Journal:  Clin Case Rep       Date:  2018-06-13

10.  Phenotype-genotype comorbidity analysis of patients with rare disorders provides insight into their pathological and molecular bases.

Authors:  Elena Díaz-Santiago; Fernando M Jabato; Elena Rojano; Pedro Seoane; Florencio Pazos; James R Perkins; Juan A G Ranea
Journal:  PLoS Genet       Date:  2020-10-01       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.